Brind.
  1. NeoGen announced strategic corporate moves, including a significant investment and partnership to create enzyme-based products, while the market awaited signals from the FED regarding interest rates and inflation.

NeoGen sold its global genomics business unit to Zoetis Inc.

2 reports, 1 independent Updated Sep 17
Gone quiet
Reports
2
Developments
1
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

NeoGen sold its global genomics business unit to Zoetis Inc.

Who's involved

What this event is mainly about
NeoGen

Keep exploring

Part of

NeoGen announced strategic corporate moves, including a significant investment and partnership to create enzyme-based products, while the market awaited signals from the FED regarding interest rates and inflation. All 2 developments

The entities involved

  • NeoGen

    international food safety company

    Nothing else this week.

Coverage

Newest first; wire copies grouped